Bio-Techne Corp. (TECH)

192.34
NASDAQ : Health Technology
Prev Close 200.44
Day Low/High 192.09 / 200.35
52 Wk Low/High 132.75 / 206.03
Avg Volume 209.50K
Exchange NASDAQ
Shares Outstanding 37.77M
Market Cap 7.57B
EPS 3.40
P/E Ratio 78.60
Div & Yield 1.28 (0.64%)
Bio-Techne Scores A Trio Of CiteAb 2019 Awards

Bio-Techne Scores A Trio Of CiteAb 2019 Awards

MINNEAPOLIS, March 5, 2019 /PRNewswire/ -- Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, was honored with three prestigious 2019 CiteAb Awards.

Bio-Techne To Present At The Barclays Global Healthcare Conference

Bio-Techne To Present At The Barclays Global Healthcare Conference

MINNEAPOLIS, March 5, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer will present at the Barclays Global Healthcare Conference on Wednesday, March 13 th, 2019, at 9:00 a.

Bio-Techne Signs Strategic Cooperation Agreement With Lisen Imprinting Diagnostics

Bio-Techne Signs Strategic Cooperation Agreement With Lisen Imprinting Diagnostics

MINNEAPOLIS, Feb. 26, 2019 /PRNewswire/ -- Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co.

Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference

MINNEAPOLIS, Feb. 20, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 8 th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27...

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend

MINNEAPOLIS, Feb. 5, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.

Bio-Techne Releases Second Quarter Fiscal 2019 Results

Bio-Techne Releases Second Quarter Fiscal 2019 Results

MINNEAPOLIS, Feb. 5, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2018.

ExoDx® Prostate(IntelliScore) (EPI) Recommended In National Comprehensive Cancer Network Guidelines For Prostate Cancer Early Detection

ExoDx® Prostate(IntelliScore) (EPI) Recommended In National Comprehensive Cancer Network Guidelines For Prostate Cancer Early Detection

MINNEAPOLIS, Jan. 31, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the National Comprehensive Cancer Network (NCCN) decision to include EPI as a recommended test in their Clinical Practice Guidelines in Oncology (NCCN...

Bio-Techne Introduces 48-Digoxigenin Cartridge For The Ella Platform

Bio-Techne Introduces 48-Digoxigenin Cartridge For The Ella Platform

MINNEAPOLIS, Jan. 29, 2019 /PRNewswire/ -- Bio-Techne today announced the launch of a new customizable cartridge format for their ProteinSimple-branded Ella™ immunoassay platform.

Bio-Techne Introduces CE-SDS PLUS For Maurice™ System

Bio-Techne Introduces CE-SDS PLUS For Maurice™ System

MINNEAPOLIS, Jan. 28, 2019 /PRNewswire/ -- Bio-Techne today announced the launch of the CE-SDS PLUS system for its ProteinSimple-branded Maurice ™ platform.

Bio-Techne Launches Cell And Gene Therapy Portfolio

Bio-Techne Launches Cell And Gene Therapy Portfolio

MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ -- Bio-Techne announces the launch of their cell and gene therapy portfolio.

Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results

Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results

MINNEAPOLIS, Jan. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, February 5, 2019, at 8:00 a.

Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference

Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 20, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 37 th Annual J.

Bio-Techne Releases GMP ROCK Inhibitor And CHIR 99021 For Stem Cell Therapy

Bio-Techne Releases GMP ROCK Inhibitor And CHIR 99021 For Stem Cell Therapy

MINNEAPOLIS, Dec. 4, 2018 /PRNewswire/ -- Bio-Techne has further added to its cell therapy portfolio by expanding the range of Tocris Bioscience-branded cGMP small molecules to include the commonly used stem cell compounds, Y-27632 (ROCK inhibitor) and...

Bio-Techne To Present At The Citi 2018 Global Healthcare Conference

Bio-Techne To Present At The Citi 2018 Global Healthcare Conference

MINNEAPOLIS, Nov. 20, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Dave Eansor, President Protein Sciences will present at the Citi 2018 Global Healthcare Conference on Wednesday, December 5, 2018, at 2:10 p.

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend

MINNEAPOLIS, Oct. 30, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.

Bio-Techne Releases First Quarter Fiscal 2019 Results

Bio-Techne Releases First Quarter Fiscal 2019 Results

MINNEAPOLIS, Oct. 30, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2018.

Bio-Techne To Present At The 2018 Stephens NY Investment Conference

Bio-Techne To Present At The 2018 Stephens NY Investment Conference

MINNEAPOLIS, Oct. 26, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2018 Stephens NY Investment Conference on Wednesday, November 7, 2018, at 10:30...

Bio-Techne Signs Strategic Cooperation Agreement With Micropoint Bioscience

Bio-Techne Signs Strategic Cooperation Agreement With Micropoint Bioscience

MINNEAPOLIS, Oct. 12, 2018 /PRNewswire/ -- Bio-Techne has entered into a strategic cooperation agreement with Micropoint Bioscience of Shenzhen, China.

Bio-Techne To Host Conference Call On October 30, 2018 To Announce First Quarter 2019 Financial Results

Bio-Techne To Host Conference Call On October 30, 2018 To Announce First Quarter 2019 Financial Results

MINNEAPOLIS, Oct. 11, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, October 30, 2018 at 8:00 a.

Bio-Techne Scientist Presented With The CASSS CE Pharm Award

Bio-Techne Scientist Presented With The CASSS CE Pharm Award

MINNEAPOLIS, Oct. 2, 2018 /PRNewswire/ -- Bio-Techne is proud to announce that one of its Principal Scientists, Jiaqi Wu, Ph.

Bio-Techne Announces Cell And Gene Therapy Initiative

Bio-Techne Announces Cell And Gene Therapy Initiative

MINNEAPOLIS, Sept. 27, 2018 /PRNewswire/ -- Bio-Techne, a global leader of research and manufacturing-grade reagents, has announced a corporate initiative to advance cell and gene therapy research and ex vivo cell processing.

Trade Wars: Winners & Losers for Investors

Trade Wars: Winners & Losers for Investors

Argus Research details 24 stocks likely to be impacted, one way or the other, by trade wars and tariffs.

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

After acquiring Amsterdam-based Patheon, TMO will continue its focus on collecting future companies into its back pocket.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANH, DVN, EXEL, FMC, FSI, GLT, MEOH, MJCO, MOH, NVO, RPXC, TECH, WU, WWE Downgrades: CIGI, IPHI, QUOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Here's a Look at 5 Stocks to Avoid

Here's a Look at 5 Stocks to Avoid

After the bullish run stocks have enjoyed for the last year, you'd better get your guard up.

A Very Large Chunk of the Stock Market Has Gone Nowhere -- So Here Is What You Should Do

A Very Large Chunk of the Stock Market Has Gone Nowhere -- So Here Is What You Should Do

These are the five stocks to play.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALLE, AXP, FSIC, ISRL, LCUT, NRZ, SID Downgrades: DAVE, HIL, IRS, KCG, PROV, TECH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Bio-Techne (TECH) Showing Signs Of Being Strong And Under The Radar

Bio-Techne (TECH) Showing Signs Of Being Strong And Under The Radar

Trade-Ideas LLC identified Bio-Techne (TECH) as a strong and under the radar candidate

Trade-Ideas: Bio-Techne (TECH) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: Bio-Techne (TECH) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Bio-Techne (TECH) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Insider Trading Alert - TECH, EWBC And CLRO Traded By Insiders

Insider Trading Alert - TECH, EWBC And CLRO Traded By Insiders

Stocks with insider trader activity include TECH, EWBC and CLRO

TheStreet Quant Rating: B- (Buy)